Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
Katharina Lankes(Technical University of Munich), Matthias Wirth(German Cancer Research Center)
Cited by 23
Related Papers
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
|Nucleic Acids Research|2014|64